Analogous to PCSK9’s action of downregulating LDLR, PCSK9 instigates MHC I reduction from cancer cell surface likely via lysosome-based degradation, in a manner that is independent of LDLR regulation [43]. The gene discussed is PCSK9; the disease is cancer.